We provide you with 20 years of free, institutional-grade data for AMRX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of AMRX. Explore the full financial landscape of AMRX stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-07 | 0001723128 | AMRX | 10-Q | Url |
| 2025-05-07 | 0001723128 | AMRX | 10-Q | Url |
| 2025-02-28 | 0001723128 | AMRX | 10-K | Url |
| 2024-11-12 | 0001723128 | AMRX | 10-Q | Url |
| 2024-08-09 | 0001723128 | AMRX | 10-Q | Url |
| 2024-05-08 | 0001723128 | AMRX | 10-Q | Url |
| 2024-03-14 | 0001723128 | AMRX | 10-K | Url |
| 2023-11-09 | 0001723128 | AMRX | 10-Q | Url |
| 2023-08-08 | 0001723128 | AMRX | 10-Q | Url |
| 2023-05-09 | 0001723128 | AMRX | 10-Q | Url |
| 2023-03-03 | 0001723128 | AMRX | 10-K | Url |
| 2022-11-07 | 0001723128 | AMRX | 10-Q | Url |
| 2022-08-08 | 0001723128 | AMRX | 10-Q | Url |
| 2022-05-06 | 0001723128 | AMRX | 10-Q | Url |
| 2022-03-01 | 0001723128 | AMRX | 10-K | Url |
| 2021-11-08 | 0001723128 | AMRX | 10-Q | Url |
| 2021-08-09 | 0001723128 | AMRX | 10-Q | Url |
| 2021-05-07 | 0001723128 | AMRX | 10-Q | Url |
| 2021-03-01 | 0001723128 | AMRX | 10-K | Url |
| 2020-11-06 | 0001723128 | AMRX | 10-Q | Url |
| 2020-08-06 | 0001723128 | AMRX | 10-Q | Url |
| 2020-05-11 | 0001723128 | AMRX | 10-Q | Url |
| 2020-03-02 | 0001723128 | AMRX | 10-K | Url |
| 2019-11-07 | 0001723128 | AMRX | 10-Q | Url |
| 2019-08-05 | 0001723128 | AMRX | 10-Q | Url |
| 2019-05-09 | 0001723128 | AMRX | 10-Q | Url |
| 2019-03-01 | 0001723128 | AMRX | 10-K | Url |
| 2018-11-07 | 0001723128 | AMRX | 10-Q | Url |
| 2018-08-09 | 0001723128 | AMRX | 10-Q | Url |
| 2018-05-15 | 0001723128 | AMRX | 10-Q | Url |
| 2018-05-07 | 0001723128 | AMRX | S-1 | Url |
| 2018-03-09 | 0001723128 | AMRX | 10-K | Url |
| 2018-03-07 | 0001723128 | AMRX | S-1 | Url |
Amneal Pharmaceuticals, Inc(NYSE:AMRX) 
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates in three segments: Generics, Specialty, and AvKARE. The Generics...
Website: http://www.amneal.com
Founded: 2002
Full Time Employees: 5,500
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report about AMRX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.